Skip to main content
World Congress on Medical Oncology
Olympic Paris 2024
Test 4
Test 1
Test 2
Test 5
Test 3
Test clone mv
Olympic Paris 2024
Olympic Paris 2024 - VIP - Boss Ticket
Olympic Paris 2024
Finance Code Test
Concrete Institute of Australia’s Biennial National Conference 2025
Concrete Institute of Australia’s Biennial National Conference 2025
Test Goldenowl Conference
Virtual Event 01
Paris Olypmpic Clone 12.09 webinar
7th World Congress of Nanoentomology
NDS NAB Transact testing
JC test 01
Pre-Release 3 Oct
DEX (Digital Employee Experience) conference 2024
test derek
TimeZone Test
TimeZone Test
Talent Events
Event Demo
Olympic Paris 2024 x
original event name for cloning testing
Olympic Paris 2024
Default payment method test
evexus Event - 509
Default payment method test2
Test Worker
Test Worker
charlie test
Arinex 1
NET24 Ho Chi Minh City Workshop 2024
Telefilm 2024 - International Exhibition of Film and Television Technology in Vietnam
Olympic Paris 2024
charlie test 2711
charlie test 2711 cloned
CICM SecurePay testing
The AI Submit 2024
Test webinar 04.12 - - - -
Taylor Swift Clone 04
Taylor Swift Clone 02
Taylor Swift
Taylor Swift Clone
Taylor Swift Clone 01
Import Test
The Trading Summit 2024 (HCM - Vietnam)
Electric Dreams: A Synthwave Extravaganza
Taylor Swift 16
Taylor Swift 12
Taylor Swift 14
Taylor Swift 15
Taylor Swift 17
Taylor Swift 20
Coin Based Hackathon 2024
Rose 01
Import Ticket
Vu Cat Tuong
STEM 1
Kids STEM
CLONE Innovate 2025: A Future Forward Summit
Innovate 2025: A Future Forward Summit
Petals & Sunshine Festival
webinar 05/02
Science
evexus Event - 273
evexus Event - 275
Association webinar 5.2
evexus Event - 274
Aurora Nights 2025 - Webinar
Seoul AI Seminar
Webinar Event - Lily AI - 20/02
evexus Event - 287
Taylor Swift 11
Swifties Only Social Contact
cloned event for Bree QA
evexus Event - 288
evexus Event - 289
Bree QA event
Tim's event
Ralph's event
Tim cloned enable all
Ralph clone event the last one
Hawaii AI Seminar
evexus Event - 293
Tokyo Seminar
Indiana AI Seminar
Registration ticket 2025
TechNova Summit
Event - 28 - 03 - 2025
TechNova Summit [2]
TechNova Summit [3]
Tech v1
Event 28/03/2025
Job Affairs
Fan Job
Webinar Event - Lily AI - 04/03
Event Registration
Association webinar 20.2
Fan's stock query
Registration
Aurora Nights 2025
Ralph test email
Taylor Swift 13
The Core 2025
Rose
The Thirdweb submit
Stress Test Conference 2026
Alan'event
World Congress of Medical Oncology
The AI Seoul Submit 2026
The Core 2026
Times are shown in your local time zone GMT
Extremes of Age versus Middle Decades of Life: A Population-Based Analysis of Colorectal Cancer Survival in Queensland, Australia
Poster
Talk Description

Institution: The University of Queensland - Queensland, Australia

Abstract Introduction Colorectal cancer (CRC) may behave differently depending on the patient’s age at diagnosis. This study evaluated the effect of decade of life at diagnosis on the five-year cancer-specific and the five-year stage-specific survivals (5YCSS and 5YSSS, respectively). The authors hypothesized that both 5YCSS and 5YSSS would be poorer at extremes of age (EoA) compared to middle decades of life (MDoL). Methods Data was sourced from Queensland Oncology Repository (QOR) and held by Cancer Alliance Queensland. Patients diagnosed between 01/01/2001 and 31/12/2021 were allocated into 10-year age groups and survivals were compared. Descriptive statistics, Pearson Chi square, Cox regression analysis, logistic regression, and Cramer’s V were used. A p-value <0.05 was considered significant. Results Out of 56,768 patients, 44,836 were included in the 5YCSS analysis and 29,906 were included in the 5YSSS analysis. The highest 5YCSS of 74.20% belonged to patients 50–59 years, who were selected as the reference group. In comparison, patients under 30 years had a lower 5YCSS of 66.22% (p <0.005) and patients older than 80 years had the lowest 5YCSS of 58.78% (p <0.001). Over-80 years and under-30 years Stage IV patients had the lowest 5YSSS of 3.57% and 15.87%, respectively. Conclusion: Patients diagnosed at EoA had a poorer 5YCSS compared to patients diagnosed in MDoL. Stage IV patients at EoA had poorer 5YSSS compared to patients in MDoL. This finding may be a result of more aggressive behaviour of CRC in young patients, within each stage, and increased frailty and comorbidity in older patients.
Speakers
Contributors
Authors

Mr Shahab Valizadehzare - , Dr Cian Keogh - , Dr Alexandra Edmundson - , Prof. David A. Clark -

Other Suggested ePosters
Privacy Statement Header

By confirming your acceptance below, you agree to our Privacy Policy